We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02731729
Brief Title: Ipilimumab vs Ipilimumab Plus Nivolumab in Patients With Stage III-IV Melanoma Who Have Progressed or Relapsed on PD-1 Inhibitor Therapy

First Submitted : April 4, 2016
First Submitted that Met QC Criteria : April 6, 2016
First Posted : April 7, 2016 (Estimate)

Results First Submitted : January 12, 2021
Results First Submitted that Met QC Criteria : February 2, 2021
Results First Posted : February 21, 2021

Last Update Submitted that Met QC Criteria : December 21, 2022
Last Update Posted : December 23, 2022